Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dna X (SONM) Cost of Revenue (2018 - 2025)

Dna X (SONM) has disclosed Cost of Revenue for 8 consecutive years, with $14.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cost of Revenue rose 33.44% year-over-year to $14.4 million, compared with a TTM value of $60.7 million through Sep 2025, down 37.08%, and an annual FY2024 reading of $48.4 million, down 34.9% over the prior year.
  • Cost of Revenue was $14.4 million for Q3 2025 at Dna X, up from $3.4 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $68.6 million in Q4 2023 and bottomed at $1.5 million in Q3 2022.
  • Average Cost of Revenue over 5 years is $16.0 million, with a median of $10.8 million recorded in 2024.
  • Peak annual rise in Cost of Revenue hit 2385.83% in 2022, while the deepest fall reached 88.07% in 2022.
  • Year by year, Cost of Revenue stood at $2.1 million in 2021, then surged by 2385.83% to $52.5 million in 2022, then soared by 30.77% to $68.6 million in 2023, then tumbled by 42.23% to $39.6 million in 2024, then crashed by 63.66% to $14.4 million in 2025.
  • Business Quant data shows Cost of Revenue for SONM at $14.4 million in Q3 2025, $3.4 million in Q2 2025, and $3.2 million in Q1 2025.